Validation of a Modified Fibrinogen on Admission with Trauma (FibAT) Score in the Australian Setting

Grant ID: EMJS-430R39-2023-BODNAR

Project Summary

Soon after injury, some individuals develop a condition where their body doesn't clot properly, leading to increased blood transfusions and increased mortality. An important aspect of clotting is a protein called fibrinogen which forms the scaffolding on which clots are formed. Fibrinogen is the first aspect of clotting that is impaired, but it is easily replaced if it is recognised with a specific blood test. Unfortunately this blood test may not be available rapidly in rural hospitals, which may lead to a delay in recognition. A scoring system called the Fibrinogen on Admission for Trauma (FibAT) has been developed in France, but includes criteria/interventions which we don't routinely do in Australia. In this study we will evaluate the FibAT's accuracy in detecting low levels of fibrinogen using data from 3 Queensland trauma centres. We will only use criteria that is available in rural settings.
This study is expected to show that even a modified FibAT is quite good at ruling in low fibrinogen so that it can be replaced early when a patient arrives in a rural hospital.


Amount Awarded


Grant Scheme


Principal Investigator:
Dr Daniel Bodnar

Co Investigators:
Prof Martin Wullschleger

Associate Investigators:
Ms Robyn Charles
Dr Glenn Ryan
Dr Jessica Forbes
Dr Julian Wong
Prof Alfred Lam
A/Prof Emma Bosley


Collaborating Institutions

CONTACT US +61 7 3720 5700 Suite 1B, Terraces, 19 Lang Parade, Milton Qld 4064